PrognomIQ

PrognomiQ Is Enabling Early Disease Detection And Treatment

San Mateo, United States · Founded 2020 · $135.0M raised

Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$135.0M
Last Round
$34.0M Series CNov 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

PrognomiQ is a diagnostics company developing multi-omic blood tests for early detection and treatment of cancer and other complex diseases. By combining proprietary proteomics data at unprecedented scale with genomic and metabolomic data, the company builds transformative liquid biopsy products, including Provue Lung for early-stage lung cancer identification.

Summary

PrognomIQ is a Biotech company based in San Mateo, United States, founded in 2020. It has raised $135.0M in total across 3 rounds, most recently a $34.0M Series C round in Nov 2024. Investors include Seer Inc, Wing VC and Maverick Ventures.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CNov 2024
$34.0M

Sign up to see all 3 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PrognomIQ on Indexed.vc
<a href="https://indexed.vc/companies/prognomiq"><img src="https://indexed.vc/api/badge/company/prognomiq" alt="PrognomIQ on Indexed.vc" width="260" height="76" /></a>